Want to join the conversation?
$EQR lifted 2015 normalized FFO per share guidance to range of $3.43-3.47 from previous forecast of $3.39-3.45. $EQR raised 2015 same store revenue change outlook to 5.2% from prior estimate of 4.75-5% and same store net operating income change guidance to 6.2% from prior forecast of 5.5-6%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?